StocksRunner logo
search
 
menu
 
  Overview  
  
  Trending  
  
  Gainers  
  
  Losers  
  
  Volume  
  
  Earnings  
  
  Upgrades  
  
  Downgrades  
  
  Option Activity  
  
  Target Price  
  
  Technical  
 
 
 
FAQ for Top Upgrades Stocks
 

What are Top Upgrades Stocks?

Top upgrades stocks are those that analysts have recently upgraded, often signaling improved expectations for performance or valuation.

Why do analysts upgrade stocks?

Analysts upgrade stocks based on factors like improved earnings potential, favorable industry trends, or enhanced company fundamentals.

How does an upgrade affect stock prices?

An upgrade can boost stock prices as it reflects increased investor confidence and attracts more buyers.

What does a price target increase mean?

A price target increase indicates that analysts expect the stock to reach a higher value within a specific timeframe.

Should I follow analyst upgrades blindly?

While analyst upgrades provide valuable insights, it’s important to conduct your own research and consider your investment strategy.

What role do fundamentals play in upgrades?

Upgrades often rely on improved fundamentals like revenue growth, profit margins, or strong market positioning.

Are upgrades only for large-cap stocks?

No, upgrades can apply to stocks of all sizes, including small-cap and mid-cap stocks with strong growth potential.

How can I track top upgrades?

You can track top upgrades through financial news platforms, stock analysis websites, or subscription services that provide analyst ratings.

What’s the difference between an upgrade and a downgrade?

An upgrade signals improved expectations, while a downgrade reflects reduced confidence in a stock’s performance.

 
StocksRunner

Get all the pieces of the puzzle on important data activity and Stay Ahead: Stock Market Updates, Expert Analysis, and Future Predictions

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Stay Informed with StocksRunner

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Our Services

Real-time stock market updates

Expert stock analysis

Investment strategies

Top stock recommendations

In-Depth Stock Analysis

Stock Sentiment Visualization

Daily Alerts for Stock Market Insights

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: Past performance, whether actual or indicated by historical tests, is not indicative of future success. Results are based on strategies not previously available to investors and may not reflect actual investor returns. Readiness and Sentiment Indicators, as well as the total score, are calculated using historical data and assumptions integral to the model, and they may be subject to losses. Active trading may not be suitable for individuals with limited resources, investment experience, or a low-risk tolerance. Your capital is at risk.

Please note that StocksRunner and its affiliates ("TS") do not offer, solicit, or endorse securities, derivatives, investment advice, or strategies of any kind. This information is for illustrative purposes only. Do not rely on it for investment decisions. Before making any investment, we recommend considering its appropriateness for your situation and seeking relevant financial, tax, and legal advice.

 
 
StocksRunner logo
 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Earnings
 
 
Top Banner
 
 
 
 
 

Top Upgrades in the Headlines

 
 
 
 

Archer Aviation Q2 Disappoints: First Revenue Stream In Sight?. Shares of).Here are some key analyst takeaways.JPMorgan reiterated a Neutral rating and price target of $10.Needham reaffirmed a Buy rating and price target of $13.HC Wainwright analyst Ami

3 Hours Ago

 
 
 

 

Ready For Take-Off: Maintaining Archer Aviation With A Buy.

5 Hours Ago

 
 
 

 

This Assurant Analyst Begins Coverage On A ish Note. Here Are Top 3 Initiations For Tuesday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades downgrades and initiations

2 Hours Ago

 
 
 

 

Is American Express Winning the Loyalty Battle Against Fintechs?. AXP leverages its rewards program premium perks and digital upgrades to retain loyalty against fintech rivals.

3 Hours Ago

 
 
 

 

CarGurus: Upgrade To Buy As The Equity Story Is Now A Lot Cleaner And Better.

4 Hours Ago

 
 
 

 

Clearwater Analytics rises after rating upgrade at Goldman Sachs.

4 Hours Ago

 
 
 

 

Goldman Sachs upgrades this software provider ahead of September investor day . Clearwater Analytics core business is consistently growing free cash flow at more than 20% annually according to Goldman Sachs.

5 Hours Ago

 
 
 

 

Ecolab Stock Cleans Up Its Relative Strength Rating. A Relative Strength Rating upgrade for Ecolab shows improving technical performance. Will it continue?The post Ecolab Stock Cleans Up Its Relative Strength Rating appeared first on Investor'.s Busin

3 Hours Ago

 
 
 

 

Ecolab Stock Cleans Up Its Relative Strength Rating. A Relative Strength Rating upgrade for Ecolab shows improving technical performance. Will it continue?The post Ecolab Stock Cleans Up Its Relative Strength Rating appeared first on Investor'.s Busin

3 Hours Ago

 
 
 

 

Excelerate Energy upgraded at Wells Fargo as growth opportunities expand.

3 Hours Ago

 
 
 

 

Enbridge Stock Sees IBD RS Rating Rise To 73. A Relative Strength Rating upgrade for Enbridge shows improving technical performance. Will it continue?The post Enbridge Stock Sees IBD RS Rating Rise To 73 appeared first on Investor'.s Business Daily.

3 Hours Ago

 
 
 

 

Whats Going On With Etsy Stock?. Shares of ) are trading higher Tuesday adding to gains of approximately 18% over the past week. Here’.s what investors .While total gross merchandise sales for the second quarter declined by 4.8% year-over-year to $2.

3 Hours Ago

 
 
 

 

Defense Stock Breaks Out After Earnings Analyst Upgrade. Raymond James upgraded Mercury Systems to strong buy after the defense technology firm cleared Q4 expectations.The post Defense Stock Breaks Out After Earnings Analyst Upgrade appeared first on Inve

5 Hours Ago

 
 
 

 

Micron Technology: Improved Guidance And AI-Driven Catalysts Equal A Strong Buy.

12 Hours Ago

 
 
 

 

Micron Rides AI Wave With Upgraded Outlook Analysts See More Gains Ahead. ) extended gains Tuesday after boosting its August-quarter outlook fueled by surging demand and pricing for AI-focused memory chips signaling continued momentum in the DRAM market t

3 Hours Ago

 
 
 

 

Parker-Hannifin: Solid Execution And Upgraded Forecast Justify Target Price Increase (Upgrade).

4 Hours Ago

 
 
 

 

This Starbucks Analyst Turns ish. Here Are Top 5 Upgrades For Tuesday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades downgrades and initiations please see our analys

2 Hours Ago

 
 
 

 

Baird upgrades Starbucks says the turnaround picture is becoming clear. Starbucks may be set up for gains as its turnaround strategy takes hold over the coming quarters according to Baird.

5 Hours Ago

 
 
 

 

SkyWests Buy Rating Reflects Operational Strength Cash Flow And Growth Outlook.

4 Hours Ago

 
 
 

 

All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy. Verona Pharma (VRNA) might move higher on growing optimism about its earnings prospects which is reflected by its upgrade to a Zacks Rank #2 (Buy).

5 Hours Ago

 
 
 

 

All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy. Verona Pharma (VRNA) might move higher on growing optimism about its earnings prospects which is reflected by its upgrade to a Zacks Rank #2 (Buy).

5 Hours Ago

 
 
 

 

All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy. Verona Pharma (VRNA) might move higher on growing optimism about its earnings prospects which is reflected by its upgrade to a Zacks Rank #2 (Buy).

5 Hours Ago

 
 
 

 

Xeris Biopharma (XERS) Upgraded to Buy: Heres Why. Xeris Biopharma (XERS) might move higher on growing optimism about its earnings prospects which is reflected by its upgrade to a Zacks Rank #2 (Buy).

5 Hours Ago

 
 
 

 

Xeris Biopharma (XERS) Upgraded to Buy: Heres Why. Xeris Biopharma (XERS) might move higher on growing optimism about its earnings prospects which is reflected by its upgrade to a Zacks Rank #2 (Buy).

5 Hours Ago

 
 
 

 
 
 
 
 
StocksRunner

Find out what happening right now and get all the pieces of the puzzle on important data activity before the major news sources break the story and see what are the trends

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stocks analysis

Stocks trends

Stocks performance

Stocks analysis

Investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.